32
Participants
Start Date
July 31, 2012
Primary Completion Date
November 30, 2012
Study Completion Date
November 30, 2012
Salmeterol
At visit 1 the sympathetic activity will be registered using microneurographic recordings of efferent muscle sympathetic nerve activity (MSNA) in the peroneal nerve and respiration over 2 hours, after 20 minutes of recording, 1 dose of placebo will be administered and after a further recording period of 45 minutes a dose of salmeterol 50 µg will be administered which will be followed by a further period of data registration. At visit 2 following 4 weeks of inhaled treatment with salmeterol the same procedures will be performed but a placebo inhalation will not be performed.
GSK Investigational Site, Göttingen
Lead Sponsor
GlaxoSmithKline
INDUSTRY